SA
Sign upLog In

Bioventus Class A Inc (BVS)

R&D Expenses

$11.57M

TTM · Period ending: · USD

BVS logo

BVS R&D Expenses

Latest reported$11.57M
BVS TTM R&D Expenses ($11.92M → $11.57M)
High-resolution chart · PNG

BVS r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bioventus Class A Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
11,570,000
11,569,000
12,113,000
12,352,000
13,237,000
14,275,000
13,891,000
13,907,000
13,114,000
12,302,000
13,446,000
16,991,000
18,590,000
21,558,000
24,715,000
25,011,000
26,550,000
25,020,000
19,039,000
14,827,000
12,243,000
10,003,000
11,202,000
11,156,000
10,731,000
10,666,000
11,924,000
11,746,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.